5-Lipoxygenase inhibitors
    2.
    发明授权
    5-Lipoxygenase inhibitors 失效
    5-脂氧合酶抑制剂

    公开(公告)号:US5028629A

    公开(公告)日:1991-07-02

    申请号:US500820

    申请日:1990-03-28

    摘要: This invention relates to 2-(substituted)-N-hydroxy-N-alkylcinnamamides of the formula: ##STR1## where R.sup.1 is C.sub.1 -C.sub.4 alkyl;n is 0 or 1;R.sup.2 is trifuloromethyl, C.sub.1 -C.sub.10 alkyl, phen(C.sub.1 -C.sub.4)alkylene or ##STR2## where m is 0, 1 or 2 and R.sup.3 is C.sub.1 -C.sub.4 alkyl; X is C.sub.1 -C.sub.6 alkyl, phenyl, phen(C.sub.1 -C.sub.4)alkylene where the phenyl ring is unsubstituted or monosubstituted with --S(O).sub.m --R.sup.3 and m and R.sup.3 are as defined above, or ##STR3## where m is 0, 1 or 2 and R.sup.4 is C.sub.2 -C.sub.12 alkenyl, C.sub.2 -C.sub.12 alkynyl, or unsubstituted or monosubstituted C.sub.1 -C.sub.20 alkyl where the substituent is CF.sub.3, C.sub.3 -C.sub.8 cycloalkyl, or phenyl,or a pharmaceutically acceptable salt thereof; formulations containing those compounds and methods of using such compounds as 5-lipoxygenase inhibiting agents.

    摘要翻译: 本发明涉及下式的2-(取代的)-N-羟基-N-烷基肉桂酰胺:其中R 1是C 1 -C 4烷基; n为0或1; R 2是三氟甲基,C 1 -C 10烷基,苯基(C 1 -C 4)亚烷基或者其中m是0,1或2,R 3是C 1 -C 4烷基; X是C 1 -C 6烷基,苯基,苯基(C 1 -C 4)亚烷基,其中苯环未被取代或被-S(O)m -R 3单取代,m和R 3如上所定义,或者其中m是0 或其药学上可接受的盐,其中R 1是C 1 -C 12链烯基,C 2 -C 12炔基或未取代的或单取代的C 1 -C 20烷基,其中取代基是CF 3,C 3 -C 8环烷基或苯基; 含有这些化合物的制剂和使用这些化合物作为5-脂氧合酶抑制剂的方法。